Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group (Q41842569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

9

Robert C Seeger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

Wendy B London

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

11

Katherine K Matthay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

8

John M Maris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Julie R Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Judith G Villablanca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Robert B Gerbing

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Daphne Haas-Kogan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

E Stanton Adkins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Edward F Attiyeh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Children's Oncology Group

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

language of work or name

1 reference

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

published in

Pediatric Blood & Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

44-50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

Chromosome 1p and 11q deletions and outcome in neuroblastoma

24 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Molecular biology of neuroblastoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

The International Neuroblastoma Pathology Classification (the Shimada system).

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Hyperdiploidy Plus NonamplifiedMYCNConfers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

2 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2731719

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas

2 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18937318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Significance of chromosome 1p loss of heterozygosity in neuroblastoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18937318

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/PBC.21784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18937318%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

18937318

1 reference